Summary: Dato’ Dr Mohd Nazlee Kamal is the CEO of Malaysian Biotechnology Corporation, a government agency responsible for executing the objectives of the National Biotechnology Policy (NBP). He spoke with The Prospect Group about the company’s new initiatives, the funding and operating environment for the biotech industry in Malaysia, and the best opportunities for investment throughout the sector.
